Newsroom | 22477 results
Sorted by: Latest
-
BIOQUAL Presents Financial Results for Fiscal Year 2025
ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pinksheets): 2025 2024 Revenue $ 48,867,753 $ 58,590,949 (Loss) Income Before Income Tax $ (1,896,010 ) $ 476,447 Net (Loss) Income $ (1,048,154 ) $ 483,481 Basic Earnings per Share of Common Stock $ (1.17 ) $ .54 Diluted Earnings per Share of Common Stock $ (1.17 ) $ .54 Weighted Average Number of Shares Outstanding For Basic Earnings Per Share 894,416 894,416 Weighted Average...
-
Wadhwani AI Global se lance pour apporter des solutions d’IA en Afrique, en Amérique latine et dans d’autres pays en développement
NEW YORK--(BUSINESS WIRE)--Wadhwani AI Global a annoncé aujourd’hui son lancement dans les pays du Sud, en ciblant l’Afrique, l’Amérique latine et d’autres pays à revenu faible ou intermédiaire. Wadhwani AI Global s’associera à des gouvernements, organisations multilatérales et organisations locales afin d’intégrer directement l’IA dans les systèmes publics essentiels, transformant ainsi les soins de santé, l’accès à l’éducation et les systèmes agricoles pour ceux qui en ont le plus besoin. Cet...
-
Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of RSV in Infants During Their First RSV Season...
-
Wadhwani AI Global Launches to Bring AI Solutions to Africa, Latin America, and Other Developing Countries
NEW YORK--(BUSINESS WIRE)--Wadhwani AI Global today announced its launch across the Global South, targeting Africa, Latin America, and other low and middle-income countries....
-
Feinstein Institutes’ Scientists Identify Potential Metabolic Pathway to Increase Septic Survival
MANHASSET, N.Y.--(BUSINESS WIRE)--Researchers are closing in on new ways to control dangerous levels of inflammation, a hallmark of sepsis which arises when the body’s response to an infection damages its own tissues and organs, often leading to organ failure or death. Investigators at Northwell Health’s Feinstein Institutes for Medical Research published in Advanced Science their discovery of a unique way our bodies control dangerous inflammation during sepsis at the cellular level, and that b...
-
New Second Edition of “Healthier Workplaces and Schools” eBook Provides Streamlined Content for Employers and Schools
FALLS CHURCH, Va.--(BUSINESS WIRE)--Following the popularity of the Healthier Workplaces and Schools eBook, 2024 Edition, AIHA—the association for scientists and professionals committed to preserving and ensuring occupational and environmental health and safety in the workplace and community—has released a new streamlined second edition. As more workplaces and schools enter flu and cold season, employers and facilities are examining their health protocols to minimize the risk of airborne infect...
-
FUJIFILM Biotechnologies Expands Strategic Partnership with argenx to Include U.S. Manufacturing Operations
HOLLY SPRINGS, N.C.--(BUSINESS WIRE)--FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization for biologics, vaccines, and advanced therapies, today announced a significant expansion of its global partnership with argenx SE, a global immunology company. As part of the expanded agreement, FUJIFILM Biotechnologies will initiate manufacturing of argenx’ drug substance for efgartigimod at the Holly Springs, North Carolina, site in 2028. argenx is the first anno...
-
Corner Therapeutics Appoints Biotech Pioneer John Maraganore as Strategic Adviser
WATERTOWN, Mass.--(BUSINESS WIRE)--Corner Therapeutics, an in vivo T cell modulation and immunotherapy company pioneering novel approaches to cancer and infection, today announced that biotech pioneer John Maraganore, Ph.D. has joined the company as a strategic adviser. Dr. Maraganore will advise Corner on corporate strategy, business development, and the advancement of its dendritic cell-initiated T cell engineering (DCITE) platform with a goal of developing its pipeline of novel immunotherapi...
-
Infinimmune Announces Research Collaboration with Immunome
ALAMEDA, Calif.--(BUSINESS WIRE)--Infinimmune Announces Research Collaboration with Immunome...
-
Acadia Healthcare to Participate in Jefferies 2025 Healthcare Services Conference
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in a fireside chat at the Jefferies 2025 Healthcare Services Conference, September 29 - 30, 2025, in Nashville, Tennessee. In connection with the conference, there will be an online webcast of the Company’s presentation available on the Company’s website starting at 8:35 a.m. Central Time / 9:35 a.m. Eastern Time on Monday, September 29, 2025. The live webcast of th...